The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2020
Filed:
Apr. 30, 2013
Applicant:
Wyeth Llc, Madison, NJ (US);
Inventors:
Laurence Moore, Newton, MA (US);
Charles Zacharchuk, Westford, MA (US);
Sridhar K. Rabindran, Chestnut Ridge, NY (US);
Assignee:
Wyeth LLC, New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 31/436 (2006.01); A61K 31/4709 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 31/436 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01);
Abstract
A combination of temsirolimus and trastuzumab in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of a trastuzumab and a HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing trastuzumab, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.